NIR-II bioimaging of small organic molecule

range (NIR-I region: 700-900 nm; NIR-II region: 1000-1700 nm). [15][16][17][18][19][20] Deep tissue penetration can be realized in this spectral range owing to the low degree level of photon absorption, scattering, and autofluorescence from tissues. [21,22] Therefore, imaging and therapeutic agents which operate in the DR to NIR region are highly desired. For CDs, strong PL in the blue and green region has been reported on numerous occasions, with PL quantum yields (QY) up to 90%, [23,24] while CDs with efficient longer wavelength emission have experienced extensive development only recently. Starting from the first report on the orange emissive CDs (PL peak at 580 nm) with a PL QY of 46%, [25] red emissive CDs with PL peak at 628 nm and PL QY of 53%, [26] and NIR emissive CDs with PL peak at 715 nm and PL QY of 43% [27] were introduced. A number of strategies, such as enlarging the π-conjugated structure, enhancing the surface oxidation, and employing proper precursors such as phenylenediamines were proved as effective for realization of such CDs. This review starts from summary of synthetic strategies toward CDs with absorption/PL at the wavelength from 650 nm and into the NIR-I and NIR-II spectral region. We then consider in detail the Stokes and anti-Stokes PL (ASPL), chemiluminescence (CL) and formation of reactive oxygen species (ROS) for the DR/NIR CDs. At the end, we provide a concise summary of already reported biomedical applications of CDs, such as in the photoacoustic (PA) imaging and photothermal therapy (PTT), photodynamic therapy (PDT), and their use as bioimaging agents and drug carriers.Carbon dots (CDs) represent a recently emerged class of luminescent materials with a great potential for biomedical theranostics, and there are a lot of efforts to shift their absorption and emission toward deep-red (DR) to near-infrared (NIR) region falling in the biological transparency window. This review offers comprehensive insights into the synthesis strategies aimed to achieve this goal, and the current approaches of modulating the optical properties of CDs over the DR to NIR region. The underlying mechanisms of their absorption, photoluminescence, and chemiluminescence, as well as the related photophysical processes of photothermal conversion and formation of reactive oxygen species are considered. The already available biomedical applications of CDs, such as in the photoacoustic imaging and photothermal therapy, photodynamic therapy, and their use as bioimaging agents and drug carriers are then shortly summarized.The ORCID identification number(s) for the author(s) of this article can be found under https://doi.org/10.1002/smll.202102325. Figure 12. a) In vivo NIR fluorescence images of a mouse stomach before (left) and after (right) gavage injection of CDs in PVP aqueous solution.Reproduced with permission. [46] Copyright 2018, Wiley-VCH. b) NIR fluorescence images of mouse tumor after intravenous injection of CDs at various time points. c) NIR fluorescence of H22 tumors that were dissected from mice at ...

show abstract

“…

…”

mentioning

confidence: 99%

Optical Properties of Carbon Dots in the Deep‐Red to Near‐Infrared Region Are Attractive for Biomedical Applications

Ushakova

Rogach

et al. 2021

Small

112

101

View full text Add to dashboard Cite

show abstract

“…The ROS HO• can synergize the chemotherapy by a cascade of bioreactions ( Figure 9 ). In addition, PDT is a promising clinical cancer treatment strategy, and it is also a common means of increasing ROS content and enhancing ROS-induced anticancer strategy [ 88 , 89 , 90 , 91 , 92 ]. PDT converts O 2 into ROS by light-activated PSs, while CDT generates cytotoxic •OH by an in situ Fenton or Fenton-like reaction between H 2 O 2 and catalysts [ 93 , 94 ].…”

Section: Activated Cascade Reactions To Enhance Ros-induced Cancer Therapymentioning

confidence: 99%

Application of Nano-Drug Delivery System Based on Cascade Technology in Cancer Treatment

Sun

2021

IJMS

View full text Add to dashboard Cite

In the current cancer treatment, various combination therapies have been widely used, such as photodynamic therapy (PDT) combined with chemokinetic therapy (CDT). However, due to the complexity of the tumor microenvironment (TME) and the limitations of treatment, the efficacy of current treatment options for some cancers is unsatisfactory. Nowadays, cascade technology has been used in cancer treatment and achieved good therapeutic effect. Cascade technology based on nanotechnology can trigger cascade reactions under specific tumor conditions to achieve precise positioning and controlled release, or amplify the efficacy of each drug to improve anticancer efficacy and reduce side effects. Compared with the traditional treatment, the application of cascade technology has achieved the controllability, specificity, and effectiveness of cancer treatment. This paper reviews the application of cascade technology in drug delivery, targeting, and release via nano-drug delivery systems in recent years, and introduces their application in reactive oxygen species (ROS)-induced cancer treatment. Finally, we briefly describe the current challenges and prospects of cascade technology in cancer treatment in the future.

show abstract

“…Biomedical imaging in NIR-II window can fully improve the temporal and spatial resolution of imaging (about 50 ms and about 25 µm) and penetration depth (up to 10 mm), obtain better image quality and signal-to-background ratio than NIR-I ( He et al, 2018 ). NIR-II fluorescence imaging has been widely used in tumor imaging, liver imaging, small blood vessel imaging, lymph node imaging, and non-invasive dynamic cerebrovascular imaging over the past years ( Hong et al, 2014 ; Zhao et al, 2019 ; Su et al, 2021 ). NIR-II imaging can discriminate tumor lesions more effectively than NIR-I imaging and can visualize lesions that are missed in NIR-I imaging ( Zhang et al, 2021 ).…”

Section: Nir Imaging and Nir/crispr-cas9-based Imaging Systemsmentioning

confidence: 99%

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System

Qiao

Zhang

et al. 2021

Front. Chem.

View full text Add to dashboard Cite

The study of different genes, chromosomes and the spatiotemporal relationship between them is of great significance in the field of biomedicine. CRISPR-Cas9 has become the most widely used gene editing tool due to its excellent targeting ability. In recent years, a series of advanced imaging technologies based on Cas9 have been reported, providing fast and convenient tools for studying the sites location of genome, RNA, and chromatin. At the same time, a variety of CRISPR-Cas9-based imaging systems have been developed, which are widely used in real-time multi-site imaging in vivo. In this review, we summarized the component and mechanism of CRISPR-Cas9 system, overviewed the NIR imaging and the application of NIR fluorophores in the delivery of CRISPR-Cas9, and highlighted advances of the CRISPR-Cas9-based imaging system. In addition, we also discussed the challenges and potential solutions of CRISPR-Cas9-based imaging methods, and looked forward to the development trend of the field.

show abstract

NIR-II bioimaging of small organic molecule

Cited by 158 publications

References 143 publications

Optical Properties of Carbon Dots in the Deep‐Red to Near‐Infrared Region Are Attractive for Biomedical Applications

Optical Properties of Carbon Dots in the Deep‐Red to Near‐Infrared Region Are Attractive for Biomedical Applications

Application of Nano-Drug Delivery System Based on Cascade Technology in Cancer Treatment

The Advance of CRISPR-Cas9-Based and NIR/CRISPR-Cas9-Based Imaging System

Contact Info

Product

Resources

About